TruAlt Bioenergy Limited (TRUALT)
Press Release
Press Release - H1 FY27
- Revenue 1,437.98 crore +243% y-y; EBITDA 233.92 crore +532% y-y; PAT 94.27 crore from loss
- Dual-feed platform (1,300 KLPD) covers 65% capacity, enhancing flexibility and longer production
- Q2 revenue 811.10 crore (+606% y-y), EBITDA margin 12.47%
- CBG partnerships with Sumitomo and GAIL advancing; 100 million litre SAF facility planned
- H1 EBITDA margin expanded to 16.27% from 8.83%, +744 bps y-y
- Industry outlook: near balance of ethanol supply-demand; feedstock flexibility key for utilization
- SAF project at Srikakulam progressing with Honeywell UOP tech and ₹150 crore grant
- Fuel retail network expanding with 7 operational outlets, 4 under construction
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 TRUALT — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add TRUALT to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on TruAlt Bioenergy Limited
Important.
The summary above is generated automatically from TruAlt Bioenergy Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.